General Catalyst is a global venture firm founded in 2000 that has grown into one of the most aggressive AI deployers among big platforms. It led Mistral's €600M Series B, entered Anthropic's cap table, and led the record US$1.1B River AI round in 2026. Its AI portfolio spans frontier labs, defense AI and healthcare AI.
GC under Taneja frames AI in system terms — 'American leadership in AI urgently requires leadership in open-weight models' (on River AI) — pairing applied-AI bets with a policy voice that most financial VCs avoid. It is an argument the firm is willing to put money behind at the frontier of open weights.
GC's Health Assurance heritage gives it a differentiated lane: Hippocratic AI (safety-first medical LLM, backed since 2023), Formation Bio, Commure and Applied Intuition (autonomy) sit alongside its traditional health portfolio — an AI angle most generalist funds cannot claim.
Fund XII reserved ~US$1.5B for 'Creation,' a strategy that incubates AI-native companies with GC operating partners rather than waiting for external founders — an unusual structure that makes GC part founder, part fund.
Unlike AI-only funds, GC spreads across healthcare, defense, fintech and consumer; AI is its fastest-growing mandate but not its whole book. Its value to AI founders is scale capital, government-adjacent networks and the ability to lead US$1B+ rounds few others can.
General Catalyst was founded by Joel Cutler and David Fialkow and has backed 800+ companies from seed to growth. The firm has additional offices in San Francisco, New York, London, Berlin, Bangalore and Washington DC, and Jeannette zu Fürstenberg serves as president.
Disclosed GC positions in AI and AI-adjacent companies, from generalcatalyst.com company pages and funding announcements.
Entered the Claude-maker's cap table (backed since 2025; Hemant Taneja / Christopher Kauffman lead the relationship).
Backed since 2023; led its €600M Series B (2024) and followed into C and the €3B Series D (2026).
Co-led the record US$1.1B round (2026, with AMP PBC; NVIDIA/AMD strategic) for Igor Babuschkin's open-weight training company — an 'American resilience' bet.
Maker of Devin, the autonomous software engineer; GC co-led its US$1B+ Series D (May 2026) and returned in the US$2B Series E (Sep 2026).
Backed since 2017; autonomous defense systems.
Simulation and software for autonomy; GC investor.
European defense AI; GC investor (Europe franchise via La Famiglia).
Safety-first medical LLM; backed since 2023 (Taneja / Alexandre Momeni).
Work AI; among GC's top AI companies (per portfolio trackers).
AI-native email security; GC investor.
AI-powered talent marketplace; GC-backed.
Companies that built GC's franchise.
Among GC's best-known holdings.
Backed from early days through IPO.
Social media; GC investor.
CRM/marketing platform; GC investor.
Connected operations with AI; GC investor.
Payroll and benefits platform; Taneja-led investment.
No rounds led by General Catalyst are in the tracker yet. Deals will appear here as they are recorded.
The Creation strategy inside Fund XII incubates AI-native companies with GC operating partners rather than waiting for external founders — making the firm part founder, part fund. It is the growth-scale cousin of accelerator company-creation: YC standardizes US$300–500K entry cheques, while GC commits balance-sheet capital to originate companies that fit its health-assurance and national-resilience theses.
Because its AI thesis is political as well as financial: the firm stated that 'American leadership in AI urgently requires leadership in open-weight models' when co-leading River AI's record US$1.1B round (with AMP PBC; NVIDIA and AMD strategic). Most financial VCs avoid policy framing; GC pairs it with a defense book — Anduril, Helsing, Applied Intuition — where the same national-resilience logic already pays.
Because its role on the cap table is the growth lever, not the origin story. GC backed Mistral from 2023, led the €600M Series B in 2024, and followed into the €3B Series D — while Index wrote the first cheque pre-incorporation and Lightspeed led the seed. A lab this contested ends up with three specialists: originator, seed lead, scale capital.
Because its legacy lanes became AI lanes. The Health Assurance heritage gives Hippocratic AI (backed since 2023), Formation Bio and Commure a home most generalists lack; the defense franchise (Anduril since 2017, Helsing via La Famiglia) does the same for autonomy. AI is the fastest-growing mandate on a generalist book of 800+ companies — differentiated by domain, not by exclusivity.
Because the national-resilience thesis predates the AI wave that validated it: GC backed Anduril in 2017, when defense tech was unfashionable, and later added Helsing in Europe and Applied Intuition in autonomy. The same framing now underwrites River AI — open-weight models presented as national capability. The defense book is where GC's policy voice and its capital were aligned first.